COMMUNIQUÉS West-GlobeNewswire

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
01/05/2026
Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive therapeutic options to be presented by Baruch Kuppermann, M.D., Ph.D. New [...]
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
01/05/2026
Tokyo, Japan and Cambridge, UK, 1 May 202 6 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March [...]
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
01/05/2026
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable [...]
MemoPryl Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
01/05/2026
MemoPryl Scam Warning Explained: Nootropic Ingredients, Official Website Pricing, and 60-Day Refund Policy — 2026 Consumer Verification Update Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not [...]
Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026
01/05/2026
TOS-358 is a covalent, pan-mutant, α-specific PI3K inhibitor designed to address key limitations of existing PI3Kα therapies which include limited mutation coverage and poor tolerability Data will include efficacy, [...]
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
01/05/2026
NEW YORK & TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring [...]
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
01/05/2026
AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics, Inc. ("Rein" or the "Company") (NASDAQ: RNTX), a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines for [...]
Leanzene Gummies Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
01/05/2026
Leanzene Gummies Scam Warning Explained: ACV and BHB Ingredients, Official Website Pricing, and 60-Day Money-Back Policy — 2026 Update Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
01/05/2026
The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in Adjusted EBITDA and NIS 17 million in positive operating cash flow, reflecting strong resilience and consistent [...]
SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints
01/05/2026
SteelPower Ingredient Label, Pricing, and Official Availability Explained for Men Researching Male Performance Support Supplements Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
01/05/2026
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, April 30, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of [...]
YD Bio Limited Reports Full Year 2025 Financial Results
01/05/2026
TAIPEI, Taiwan, April 30, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
MyGriefAngels.org Launches "Grief @ Work Insights" Hub to Bridge the Support Gap in the Modern Workplace
30/04/2026
The groundbreaking free resource equips grieving employees and forward-thinking organizations worldwide with the policies, legislation, research, and compassionate guidance needed to navigate loss in the modern [...]
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
30/04/2026
Primary and subgroup analysis from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related chronic cough accepted for oral presentation, including key subgroup analyses by baseline cough [...]
TLX101-Px (Pixlumi®) MAA Accepted in Europe
30/04/2026
MELBOURNE, Australia and INDIANAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the marketing authorization application (MAA) filed in Europe [...]
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
30/04/2026
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable [...]
The Ensign Group Acquires Real Estate and Expands Operations in Texas
30/04/2026
SAN JUAN CAPISTRANO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
30/04/2026
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2026 [...]
FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
30/04/2026
On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026 HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a [...]

Pages